Table 3.
Coefficient | SD | OR | CI | p value | N | |
---|---|---|---|---|---|---|
(Intercept) | 2.788 | 1.190 | 16.251 | [1.730, 193.338] | NA | 94 |
Age at diagnosis (effect of 1 year less) | 0.094 | 0.033 | 1.098 | [1.033, 1.179] | <0.01 | VIF = 1.12 |
Disease durationa (effect of 1 year less) | 0.154 | 0.046 | 1.167 | [1.074, 1.287] | <0.01 | VIF = 1.17 |
MRI activity under FGL present (versus absent) | 1.070 | 0.550 | 2.916 | [1.018, 8.982] | 0.0462 | VIF = 1.09 |
CI, confidence interval; FGL, fingolimod; NA, not available; OR, odds ratio; SD, standard deviation; VIF, variance inflation factor.
Multivariate logistic model with 94 complete cases that shows that younger age at diagnosis, shorter disease duration, and presence of MRI activity under FGL are independent risk factors for postfingolimod disease activity.
Note that disease duration was calculated at fingolimod discontinuation.